{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T19:22:30Z","timestamp":1751570550371,"version":"3.40.5"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijwd.2021.06.002","type":"journal-article","created":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T15:52:49Z","timestamp":1624204369000},"page":"731-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PB","title":["Vulvar pseudotumoral acyclovir-resistant herpes in an HIV-negative, non-immunosuppressed patient: A therapeutic challenge"],"prefix":"10.1097","volume":"7","author":[{"given":"Jun","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheline","family":"Moyal-Barracco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laraine L.","family":"Washer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9007-5967","authenticated-orcid":false,"given":"Hope K.","family":"Haefner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebony","family":"Parker-Featherstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijwd.2021.06.002_bib0001","series-title":"Antiviral methods and protocols","first-page":"151","article-title":"Monitoring drug resistance for herpes viruses","author":"Andrei","year":"2000"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1468-1293.2010.00896.x","article-title":"Management of resistant mucocutaneous herpes simplex infections in AIDS patients: A clinical and virological challenge","volume":"12","author":"Barde","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0003","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijid.2020.04.025","article-title":"Hypertrophic genital herpes in an HIV-infected female patient: Imiquimod as an alternative treatment","volume":"95","author":"Barroso dos Reis","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"No. RR-3","key":"10.1016\/j.ijwd.2021.06.002_bib0004","first-page":"1","article-title":"Sexually Transmitted Diseases Treatment Guidelines, 2015","volume":"64","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcv.2016.02.023","article-title":"Pseudotumoral recto-sigmoid herpes simplex virus type 2 in an HIV-infected patient: Dramatic improvement with thalidomide","volume":"78","author":"Charles","year":"2016","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.ijwd.2021.06.002_bib0006","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/QAD.0b013e32835049be","article-title":"Anogenital pseudotumor herpes and HIV infection: A new challenge for diagnosis and treatment","volume":"26","author":"Di Lucca-Christment","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0007","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s00520-016-3264-5","article-title":"Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: Potential role of topical cidofovir","volume":"24","author":"Epstein","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0008","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/ced.12453","article-title":"Herpes simplex virus and cytomegalovirus co-infection presenting as exuberant genital ulcer in a woman infected with human immunodeficiency virus","volume":"39","author":"Gouveia","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"10.1016\/j.ijwd.2021.06.002_bib0009","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1086\/517513","article-title":"Thalidomide therapy for the treatment of hypertrophic herpes simplex virus-related genitalis in HIV-infected individuals","volume":"44","author":"Holmes","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijid.2015.02.002","article-title":"Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: A retrospective observational study","volume":"33","author":"Leeyaphan","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.ijwd.2021.06.002_bib0011","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1086\/422364","article-title":"Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients","volume":"39","author":"Levin","year":"2004","journal-title":"Clin Infect Dis"},{"year":"2018","series-title":"Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14\u201349: United States, 2015\u20132016","author":"McQuillan","key":"10.1016\/j.ijwd.2021.06.002_bib0012"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0013","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/sti.2010.047431","article-title":"Topical imiquimod treatment of acyclovir-resistant herpes simplex disease: Case series and literature review","volume":"87","author":"Perkins","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1258\/ijsa.2010.010204","article-title":"Tumour-like presentations of anogenital herpes simplex in HIV-positive patients","volume":"22","author":"Ranu","year":"2011","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM199108223250805","article-title":"A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group","volume":"325","author":"Safrin","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0016","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/cid\/cit592","article-title":"Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: Evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy","volume":"57","author":"Sbidian","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijwd.2021.06.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12479","article-title":"Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod","volume":"30","author":"Tandon","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ijwd.2021.06.002_bib0018","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(96)91463-4","article-title":"Thalidomide for genital ulcer in HIV-positive woman","volume":"347","author":"Verberkmoes","year":"1996","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ijwd.2021.06.002_bib0019","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-4632.2007.03449.x","article-title":"Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome","volume":"46","author":"Ziyaeyan","year":"2007","journal-title":"Int J Dermatol"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647521000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647521000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:28:15Z","timestamp":1641565695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647521000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2352647521000721"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2021.06.002","relation":{},"ISSN":["2352-6475"],"issn-type":[{"type":"print","value":"2352-6475"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vulvar pseudotumoral acyclovir-resistant herpes in an HIV-negative, non-immunosuppressed patient: A therapeutic challenge","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2021.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}